Clinical significance of immunoglobulin A antiphospholipid antibodies: Possible association with skin manifestations and small vessel vasculitis

Journal of Rheumatology

Volumn 25, Issue 9, 1998, Pages 1730-1736

  Tajima, Chiaki ^a,b   Suzuki, Yasuo ^a,b   Mizushima, Yutaka ^a,c   Ichikawa, Yoichi ^a,b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Medicine ^*

^c Department of Medicine

Author keywords

Antiphospholipid antibody; Immunoglobulin A; Lupus anticoagulant; Skin ulcer; Systemic lupus erythematosus; Vasculitis

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SKIN MANIFESTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODY AFFINITY; AUTOIMMUNE DISEASES; BLOOD VESSELS; COLLAGEN DISEASES; FEMALE; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN DISEASES; SKIN ULCER; VASCULITIS;

EID: 0031727660     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kampe CE. Clinical syndromes associated with lupus anticoagulants. Semin Thromb Hemost 1994;20:16-26.
2. Harris EN, Gharavi AE, Boey ML, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;2:1211-4.
3. Hughes GRV, Harris EN, Gharavi AE. The anticardiolipin syndrome [editorial]. J Rheumatol 1986;13:486-9.
4. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990; 74:1-9.
5. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990;112:682-98.
6. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
7. Galli M, Comfurius P, Maassen C, et al. Anticardiolipin antibodies are directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-7.
8. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-8.
9. Shi W, Chong BH, Chesterman CN. β2 glycoprotein I is a requirement for anticardiolipin antibodies binding to activated platelets: difference with lupus anticoagulants. Blood 1993;81:1255-62.
10. Martinuzzo ME, Maclouf J, Carreras LO, Lévy-Toleddano S. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation. Thromb Haemostas 1993;70:667-71.
11. Cariou R, Tobelem G, Bellucci S, et al. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells - inhibition of thrombomodulin dependent protein C activation. Thromb Haemost 1988;60:54-8.
12. Shi W, Chong GH, Hogg PJ, Chesterman CN. Anticardiolipin antibodies block the inhibition by β2 glycoprotein I of the factor Xa generating activity of platelets. Thromb Haemost 1993;70: 342-5.
13. Alarcón-Segovia D, Delezé M, Oria CV, et al. Antiphospholipid antibodies and the antiphopholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989;68:353-65.
14. Lopez LR, Santos ME, Espinoza LR, La Rosa FG. Clinical significance of immunoglobulin A versus immunoglobulins G and M anticardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion. Am J Clin Pathol 1992;98:449-54.
15. Weidmann CE, Wallace DJ, Peter JB, Knight PJ, Bear MB, Klinenberg JR. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus. J Rheumatol 1988;15:74-9.
16. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
17. Kalunian KC, Peter JB, Middlekauff HR, et al. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus. Am J Med 1988;85:602-8.
18. Bick RL, Baker WF. The antiphospholipid and thrombosis syndromes. Med Clin North Am 1994;78:667-84.
19. Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-8.
20. Weinstein C, Miller MH, Axtens R, Buchanan R, Littlejohn GO. Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus. Arch Dermatol 1987;123:596-600.
21. Wallace DJ. Cutaneous manifestations of SLE. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 4th edition. Philadelphia, London: Lea & Febiger; 1993:356-69.
22. Provost TT, Watson R. Pathogenesis of cutaneous manifestations of lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 4th edition. Philadelphia, London: Lea & Febiger; 1993:279-84.
23. 2-glycoprotein I-dependent anticardiolipin antibodies in rheumatic disease. Lupus 1995; Suppl 1:4:S27-S31.
24. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
25. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995;74:1185-90.
26. Triplett DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983;79:678-82.
27. Rauch J, Tannenbaum M, Janoff AS. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost 1989;62:892-6.
28. 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems. Am J Obstet Gynecol 1995;172:926-31.
29. Naldi L, Locati F, Marchesi L, et al. Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis 1993;52:219-22.
30. Allegue F, Alonso ML, Rocamora A, Ledo A. Chilblain lupus erythematosus and antiphospholipid antibody syndrome. J Am Acad Dermatol 1988;19:908-10.
31. Asherson RA, Derksen RHWM, Harris EN, et al. Large vessel occlusion and gangrene in systemic lupus erythematosus and "lupus-like" disease. A report of six cases. J Rheumatol 1986;13:740-7.
32. Burden AD, Gibson IW, Rodger RSC, Tillman DM. IgA anticardiolipin antibodies associated with Henoch-Schönlein purpura. J Am Acad Dermatol 1994;31:857-60.